5 Best Micro-Cap Stocks to Invest In

3. Cabaletta Bio, Inc. (NASDAQ:CABA)

No of Hedge Funds Holders: 12

Cabaletta Bio, Inc. (NASDAQ: CABA) is a biotechnology firm focused on the development of cellular treatments for autoimmune illnesses. This company stands third on our list of best micro-cap stocks to invest in.

On June 29, investment advisory Mizuho initiated coverage of Cabaletta Bio, Inc. (NASDAQ: CABA) stock with a Buy rating and a price target of $22, stating that it believes that the company would bring transformative innovation into immunology.

On May 3, the results of the first cohort of three patients treated with DSG3-CAART were released by the Cabaletta Bio, Inc. (NASDAQ: CABA), citing that there were no significant side effects.

Our data shows that Adage Capital Management is one of the biggest stakeholders of Cabaletta Bio, Inc. (NASDAQ: CABA) with 3 million shares worth $26.2 million.

At the end of the second quarter of 2021, 12 hedge funds in the database of Insider Monkey held stakes worth $73.1 million in Cabaletta Bio, Inc. (NASDAQ: CABA), up from 11 the preceding quarter worth $91.8 million.